GeneDx Holdings Corp. (WGS)
48.00
+0.71
(+1.50%)
USD |
NASDAQ |
Nov 18, 10:15
GeneDx Holdings Profit Margin (Quarterly) : -10.01% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -10.01% |
| June 30, 2026 | -15.50% |
| March 31, 2026 | -61.92% |
| December 31, 2025 | -14.60% |
| September 30, 2025 | -6.54% |
| June 30, 2025 | 10.53% |
| March 31, 2025 | -7.49% |
| December 31, 2024 | 5.69% |
| September 30, 2024 | -10.81% |
| June 30, 2024 | -41.37% |
| March 31, 2024 | -32.42% |
| December 31, 2023 | -44.89% |
| September 30, 2023 | -79.33% |
| Date | Value |
|---|---|
| June 30, 2023 | -95.92% |
| March 31, 2023 | -141.4% |
| December 31, 2022 | -503.3% |
| September 30, 2022 | -93.21% |
| June 30, 2022 | -237.1% |
| March 31, 2022 | -142.6% |
| December 31, 2021 | -69.52% |
| September 30, 2021 | 75.80% |
| June 30, 2021 | -98.18% |
| March 31, 2021 | -298.7% |
| December 31, 2020 | -196.5% |
| September 30, 2020 | -146.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CS Diagnostics Corp. | -- |
| Aibotics, Inc. | -- |
| Twist Bioscience Corp. | -16.28% |
| Beam Therapeutics, Inc. | -43.78K% |
| Ayujoy Herbals Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.33% |
| Return on Assets | -21.53% |
| Return on Invested Capital | -26.17% |
| Gross Profit Margin (Quarterly) | 68.63% |
| Operating Margin (Quarterly) | -7.77% |
| Return on Net Operating Assets | -32.59% |